Clinical trial
A Double-blind, Placebo-controlled, Randomized Trial to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy
NCT02435199 is registered in ClinicalTrials.gov with Spinifex Pharmaceuticals Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Placebo-controlled, Randomized Trial to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy
- Lead sponsor
- Spinifex Pharmaceuticals Pty Ltd
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- June 30, 2015
- Completion date
- December 31, 2016
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.